keyword
MENU ▼
Read by QxMD icon Read
search

Jco

keyword
https://www.readbyqxmd.com/read/28159497/intermediate-and-longer-term-outcomes-from-a-prospective-active-surveillance-program-for-favorable-risk-prostate-cancer-tosoian-jj-mamawala-m-epstein-ji-landis-p-wolf-s-trock-bj-carter-hb-j-clin-oncol-2015-oct-20-33-30-3379-85-epub-2015-aug-31-doi-10-1200-jco
#1
Eggener Scott, M Mamawala, J I Epstein, P Landis, S Wolf, Trock, H B Carter
PURPOSE: To assess long-term outcomes of men with favorable-risk prostate cancer in a prospective, active surveillance program. METHODS: Curative intervention was recommended for disease reclassification to higher cancer grade or volume on prostate biopsy. Primary outcomes were overall, cancer-specific, and metastasis-free survival. Secondary outcomes were the cumulative incidence of reclassification and curative intervention. Factors associated with grade reclassification and curative intervention were evaluated in a Cox proportional hazards model...
March 2017: Urologic Oncology
https://www.readbyqxmd.com/read/28156518/the-estimated-hospital-wide-financial-impact-of-a-comprehensive-inpatient-palliative-care-pc-program
#2
Chunhua Lu, John P McQuade, A Rab Razzak, Natasha Gill, Michael A Cardamone, Deirdre Torto, Terry Langbaum, David R Holtgrave, Thomas J Smith
173 Background: Inpatient PC improves quality of care, patient and family satisfaction, and lowers costs. PC consultation during a cancer hospital stay led to a 14 (if by day 6) to 24% (by day 2) reduction in direct cost, and especially when people had comorbidities. (May, JCO 2015; Health Affairs 2016). We attempted to discern the financial impact of both a PC inpatient unit (PCU) and PC consultations on patients in other inpatient units for a large academic medical center, the Johns Hopkins Hospital (JHH), as we prepared to expand the PCU from 6 to11 beds and increased inpatient PC consultation capacity...
October 9, 2016: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/28102529/recovery-from-chemotherapy-induced-white-matter-changes-in-young-breast-cancer-survivors
#3
Thibo Billiet, Louise Emsell, Mathieu Vandenbulcke, Ronald Peeters, Daan Christiaens, Alexander Leemans, Wim Van Hecke, Ann Smeets, Frederic Amant, Stefan Sunaert, Sabine Deprez
In a previous longitudinal diffusion tensor imaging (DTI) study, we observed cerebral white matter (WM) alterations (reduced fractional anisotropy (FA)) related to decreased cognitive performance 3-5 months after chemotherapy-treatment (t2) when compared to baseline (t1) (Deprez et al. in Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 30(3), 274-281. doi:10.1200/JCO.2011.36.8571, 2012). The current study investigates the evolution and the nature of these previously observed microstructural changes...
January 19, 2017: Brain Imaging and Behavior
https://www.readbyqxmd.com/read/27898912/feeding-value-of-supplemental-curcas-crude-oil-in-finishing-diets-for-feedlot-lambs
#4
J A Félix-Bernal, A Estrada-Angulo, M A Angulo-Escalante, B I Castro-Pérez, H Landeros-López, M A López-Soto, A Barreras, R A Zinn, A Plascencia
The objective of this experiment was to determine the feeding value of a mechanically extracted nontoxic variety of oil (JCO) as source of energy for feedlot lambs. Twenty Pelibuey × Katahdin lambs were individually fed a dry-rolled-corn-based finishing diet supplemented with 0%, 2%, 4%, or 6% JCO (diet dry matter basis). Supplemental JCO replaced dry rolled corn in the basal diet. Fatty acid composition of JCO was C16:0, 14.0%; C18:0, 8.2%; C18:1, 26.0%; C18:2, 50.3%, and C18:3, 0.4%. Daily intakes of JCO averaged 24...
September 2016: Journal of Animal Science
https://www.readbyqxmd.com/read/27391863/degradation-rates-of-phorbol-esters-in-jatropha-curcas-l-oil-and-pressed-seeds-under-different-storage-conditions
#5
Naphatsarnan Phasukarratchai, Seelawut Damrongsiri, Chantra Tongcumpou
BACKGROUND: Phorbol esters (PEs), found in Jatropha curcas crude oil (JCO) and J. curcas pressed seeds (JPS), are known as bioactive compounds in agricultural and pharmaceutical applications. The degradation rates of PEs in JCO and JPS under various conditions is important for the utilisation of PEs. Thus the objective of this study was to determine the PE degradation rates in JCO and JPS under different storage conditions. RESULTS: PE degradation rates were found to be first-order reactions...
July 8, 2016: Journal of the Science of Food and Agriculture
https://www.readbyqxmd.com/read/27161716/po-28-protein-c-levels-are-associated-with-mortality-in-patients-with-advanced-cancer
#6
I T Wilts, B A Hutten, J C Meijers, C A Spek, H R Büller, P W Kamphuisen
INTRODUCTION: In cancer, tumor progression and metastasis are promoted by prohemostatic activity. Protein C (PC) is involved in hemostasis, inflammation and signal transduction, and has a protective effect on the endothelial barrier. In mice, administration of activated PC reduced experimental metastasis. It is unclear whether PC level is associated with mortality in patients with cancer. AIM: To assess the relation between PC level and survival in patients with advanced cancer...
April 2016: Thrombosis Research
https://www.readbyqxmd.com/read/27117740/2016-eugene-l-gottlieb-jco-student-of-the-year-dr-krystian-jarosz
#7
Philip B Vogels
No abstract text is available yet for this article.
March 2016: Journal of Clinical Orthodontics: JCO
https://www.readbyqxmd.com/read/27047721/survival-in-patients-with-non-metastatic-breast-cancer-treated-with-adjuvant-trastuzumab-in-clinical-practice
#8
Christopher M Gallagher, Kenneth More, Anthony Masaquel, Tripthi Kamath, Annie Guerin, Raluca Ionescu-Ittu, Roy Nitulescu, Marjolaine Gauthier-Loiselle, Nicholas Sicignano, Elizabeth Butts, Eric Q Wu, Brian Barnett
PURPOSE: The NSABP Trial B-31 and NCCTG Trial N9831 (B-31/N9831 trials, Romond et al. in N Engl J Med 353:1673-84, 2005. doi:10.1056/NEJMoa052122; Perez et al. in J Clin Oncol 32:3744-52, 2014. doi:10.1200/JCO.2014.55.5730) established the efficacy of adjuvant trastuzumab for patients with HER2-positive early stage breast cancer. We aimed to estimate the overall survival (OS) and relapse-free survival (RFS) of HER2-positive non-metastatic breast cancer patients treated with adjuvant trastuzumab in a clinical practice setting in the United States...
2016: SpringerPlus
https://www.readbyqxmd.com/read/26799996/2015-jco-orthodontic-practice-study-part-3-practice-growth-and-staff-data
#9
Robert G Keim, Eugene L Gottlieb, David S Vogels, Philip B Vogels
No abstract text is available yet for this article.
December 2015: Journal of Clinical Orthodontics: JCO
https://www.readbyqxmd.com/read/26684841/2015-jco-orthodontic-practice-study-part-2-practice-success
#10
Robert G Keim, Eugene L Gottlieb, David S Vogels, Philip B Vogels
No abstract text is available yet for this article.
November 2015: Journal of Clinical Orthodontics: JCO
https://www.readbyqxmd.com/read/26661416/the-effect-of-electrolyte-composition-on-the-electroreduction-of-co2-to-co-on-ag-based-gas-diffusion-electrodes
#11
Sumit Verma, Xun Lu, Sichao Ma, Richard I Masel, Paul J A Kenis
The electroreduction of CO2 to C1-C2 chemicals can be a potential strategy for utilizing CO2 as a carbon feedstock. In this work, we investigate the effect of electrolytes on the electroreduction of CO2 to CO on Ag based gas diffusion electrodes. Electrolyte concentration was found to play a major role in the process for the electrolytes (KOH, KCl, and KHCO3) studied here. Several fold improvements in partial current densities of CO (jCO) were observed on moving from 0.5 M to 3.0 M electrolyte solution independent of the nature of the anion...
March 14, 2016: Physical Chemistry Chemical Physics: PCCP
https://www.readbyqxmd.com/read/26644523/adjuvant-imatinib-for-gi-stromal-tumors-when-and-for-how-long
#12
Robert S Benjamin, Paolo Giovanni Casali
A 45-year-old woman presented with syncope. She was severely anemic, with a hemoglobin level of 6 g/dL, and was found to have lower GI bleeding. A diagnostic colonoscopy was negative. A subsequent computed tomography scan of the abdomen and pelvis was performed, revealing a 3.2 × 3 × 2.9-cm contrast-enhancing right lower-quadrant mass arising from the wall of the ileum. There was no evidence of metastatic disease. The patient underwent laparotomy, and a 3.5-cm mass was resected with negative margins. Pathology revealed a GI stromal tumor with mixed spindle and epithelioid features involving the mucosa and submucosa (Fig 1A)...
January 20, 2016: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/26562391/2015-jco-orthodontic-practice-study-part-1-trends
#13
Robert G Keim, Eugene L Gottlieb, David S Vogels, Philip B Vogels
No abstract text is available yet for this article.
October 2015: Journal of Clinical Orthodontics: JCO
https://www.readbyqxmd.com/read/26059244/long-term-impacts-of-grazing-intensity-on-soil-carbon-sequestration-and-selected-soil-properties-in-the-arid-eastern-cape-south-africa
#14
Deribe G Talore, Eyob H Tesfamariam, Abubeker Hassen, J C O Du Toit, Katja Klampp, Soussana Jean-Francois
BACKGROUND: Little is known about how basic soil properties respond to contrasting grazing intensities in the Karoo biome, South Africa. The aim of this study was to investigate impacts of long-term (>75 years) grazing at 1.18 heads ha(-1) (heavy; CGH), 0.78 heads ha(-1) (light; CGL), and exclosure on selected soil properties. Soil samples were collected to a depth of 60 cm from the long-term experimental site of Grootfontein Agricultural Development Institute, Eastern Cape. The samples were analyzed for C, N, bulk density and infiltration rate, among others...
April 2016: Journal of the Science of Food and Agriculture
https://www.readbyqxmd.com/read/26049892/r%C3%A3-le-des-m%C3%A3-decins-de-famille-dans-les-soins-ophtalmologiques-actualisation-des-connaissances-de-la-part-du-jco
#15
EDITORIAL
Pierre-Paul Tellier
No abstract text is available yet for this article.
June 2015: Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie
https://www.readbyqxmd.com/read/26049888/mise-%C3%A3-jour-des-connaissances-des-m%C3%A3-decins-de-premi%C3%A3-re-ligne-en-ophtalmologie-de-la-part-du-jco
#16
EDITORIAL
Walter Delpero
No abstract text is available yet for this article.
June 2015: Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie
https://www.readbyqxmd.com/read/25937427/commentary-on-randomized-controlled-double-blind-cross-over-trial-assessing-treatment-preference-for-pazopanib-versus-sunitinib-in-patients-with-metastatic-renal-cell-carcinoma-pisces-study-escudier-b-porta-c-bono-p-powles-t-eisen-t-sternberg-cn-gschwend-je
#17
COMMENT
Commentary on: "Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES study." Escudier B, Porta C, Bono P, Powles T, Eisen T, Sternberg CN, Gschwend JE, De Giorgi U, Parikh O, Hawkins R, Sevin E, Négrier S, Khan S, Diaz J, Redhu S, Mehmud F, Cella D. Bernard Escudier, Institut Gustave Roussy, Villejuif; Emmanuel Sevin, Centre François Baclesse, Caen; Sylvie Négrier, Leon Berard Cancer Center, Lyon, France; Camillo Porta, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico S. Matteo, Pavia; Cora N Sternberg, San Camillo Forlanini Hospital, Rome; Ugo De Giorgi, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy; Petri Bono, Helsinki University Central Hospital, Helsinki, Finland; Thomas Powles, Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London; Tim Eisen, Cambridge University Health Partners, Cambridge; Omi Parikh, Royal Preston Hospital, Lancashire; Robert Hawkins, Christie Cancer Research UK, Manchester; Sadya Khan, Jose Diaz, and Faisal Mehmud, GlaxoSmithKline, Uxbridge, United Kingdom; Jürgen E Gschwend, Klinikum Rechts der Isar der Technischen Universität München, Munich, Germany; Suman Redhu, GlaxoSmithKline, Collegeville, PA; David Cella, Northwestern University Feinberg School of Medicine, Chicago, IL.: J Clin Oncol. 2014 May 10;32(14):1412-1418; doi: 10.1200/JCO.2013.50.8267. [Epub 2014 Mar 31].
Donald Trump
PURPOSE: Patient-reported outcomes may help inform treatment choice in advanced/metastatic renal cell carcinoma (RCC), particularly between approved targeted therapies with similar efficacy. This double-blind crossover study evaluated patient preference for pazopanib or sunitinib and the influence of health-related quality of life (HRQoL) and safety factors on their stated preference. PATIENTS AND METHODS: Patients with metastatic renal cell carcinoma were randomly assigned to pazopanib 800mg per day for 10 weeks, a 2-week washout, and then sunitinib 50mg per day (4 weeks on, 2 weeks off, 4weeks on) for 10 weeks, or the reverse sequence...
May 2016: Urologic Oncology
https://www.readbyqxmd.com/read/25937425/commentary-on-randomized-phase-iii-trial-of-temsirolimus-and-bevacizumab-versus-interferon-alfa-and-bevacizumab-in-metastatic-renal-cell-carcinoma-intoract-trial-rini-bi-bellmunt-j-clancy-j-wang-k-niethammer-ag-hariharan-s-escudier-b-brian-i-rini-cleveland
#18
COMMENT
Donald Trump
PURPOSE: To prospectively determine the efficacy of combination therapy with temsirolimus plus bevacizumab versus interferon alfa (IFN) plus bevacizumab in metastatic renal cell carcinoma (mRCC). PATIENTS AND METHODS: In a randomized, open-label, multicenter, phase III study, patients with previously untreated predominantly clear cell mRCC were randomly assigned, stratified by prior nephrectomy and Memorial Sloan-Kettering Cancer Center prognostic group, to receive the combination of either temsirolimus (25mg intravenously, weekly) or IFN (9MIU subcutaneously thrice weekly) with bevacizumab (10mg/kg intravenously, every 2weeks)...
May 2016: Urologic Oncology
https://www.readbyqxmd.com/read/25817969/large-scale-automatic-extraction-of-side-effects-associated-with-targeted-anticancer-drugs-from-full-text-oncological-articles
#19
Rong Xu, QuanQiu Wang
Targeted anticancer drugs such as imatinib, trastuzumab and erlotinib dramatically improved treatment outcomes in cancer patients, however, these innovative agents are often associated with unexpected side effects. The pathophysiological mechanisms underlying these side effects are not well understood. The availability of a comprehensive knowledge base of side effects associated with targeted anticancer drugs has the potential to illuminate complex pathways underlying toxicities induced by these innovative drugs...
June 2015: Journal of Biomedical Informatics
https://www.readbyqxmd.com/read/25753443/journal-honors-steven-m-corsello-md-as-recipient-of-the-2014-jco-young-investigator-award
#20
(no author information available yet)
No abstract text is available yet for this article.
April 10, 2015: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
keyword
keyword
1388
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"